Infection with bovine viral diarrhea virus (BVDV) results in major economic losses either directly through decreased productive performance in cattle herds or indirectly, such as through expenses for control programs. The aim of this systematic review was to review financial and/or economic assessment studies of prevention and/or mitigation activities of BVDV at national, regional and farm level worldwide. Once all predefined criteria had been met, 35 articles were included for this systematic review. Studies were analyzed with particular focus on the type of financially and/or economically-assessed prevention and/or mitigation activities. Due to the wide range of possible prevention and/or mitigation activities, these activities were grouped into five categories: i) control and/or eradication programs, ii) monitoring or surveillance, iii) prevention, iv) vaccination and v) individual culling, control and testing strategies. Additionally, the studies were analyzed according to economically-related variables such as efficiency, costs or benefits of prevention and/or mitigation activities, the applied financial and/or economic and statistical methods, the payers of prevention and/or mitigation activities, the assessed production systems, and the countries for which such evaluations are available.
Introduction
Bovine viral diarrhea virus (BVDV) is a Pestivirus related to both the causative agent of classical swine fever (CSF) and border disease virus (BDV), which was first described in New York in 1946 by Olafson and Rickard (1947) . BVDV exists in most cattleproducing countries worldwide (Truyers et al., 2010) . Infection leads to substantial costs to the private-public sector through decreased reproductive performance as direct losses, and increased control efforts as indirect losses (Otte and Chilonda, 2000) . The direct losses of bovine viral diarrhea infection, such as reduced milk yield, respiratory disorders, congenital defects, growth retardation, extended calving intervals, reduced first service conception, and increased mortality of animals due to immunosuppression (Houe, 1999) , can all justify the implementation of programs to prevent or mitigate the disease (Moennig et al., 2005) . Prevention activities may comprise biosecurity measures aiming to prevent transmission of infection between infected and uninfected herds, i.e. by avoiding contact with PI animals (movement restrictions) and/or vaccination and/or testing of cattle before movement . Mitigation activities may include surveillance and intervention measures . Surveillance measures intend to detect the presence or demonstrate the absence of the disease . Intervention measures such as control or eradication programs aim at reducing disease prevalence, but differ in the degree of disease reduction . Control measures aim to reduce disease prevalence to a relatively low level, while the purpose of eradication is to provide a continued absence of the disease (Andrews and Langmuir, 1963; Houe et al., 2006) by testing and removal of infected cattle. The relationship between prevention, surveillance and interventions measures and avoided production losses should be considered simultaneously from an economic point of view . High investments in prevention activities at the farm level can lead to minor costs incurred for mitigation of the disease at the national level or vice versa. With respect to BVDV, the eradication of persistently infected (PI) animals is the primary goal of mitigation programs (Lanyon and Reichel, 2013) . PI animals were infected in utero prior to 120 days' gestation and subsequently their immune systems fail to recognize the BVD virus as a non-self antigen (Tizard, 2009 ). As such, they excrete large amounts of virus, but are unable to develop specific antibodies to BVDV. PI animals are, therefore, essential in transmitting infection (Houe, 1999) and are often considered to be the primary source of BVDV introduction to a cattle herd (Niskanen et al., 2002; Smith et al., 2014; Burgstaller et al., 2016 ). In contrast, transiently infected (TI) cattle show mild clinical signs and shed small amounts of virus particles for a period of approximately 14 days (Brownlie et al., 1987) .
It is clear that mitigation activities for nonregulated animal diseases, such as BVDV in the European Union, can vary substantially between countries (Heffernan et al., 2009 ) and even within a single country, if no national form of coordination exists (Geraghty et al., 2014) . The degree of variation in mitigation activities depends on the perceived importance of the disease by policy makers (Heffernan et al., 2009 ), the geographical level at which mitigation activities are implemented ; such as national, regional or farm level) and/or whether compulsory or voluntary regulations exist; all of which have an influence on the costs and benefits of the implemented measures.
The lack of economic data relating to the prevention and/or mitigation activities of animal diseases has been discussed in many veterinary studies (Drewe et al., 2012; Pinior et al., 2015a,b) . As yet, no global review exists that provides information on the availability of financial and/or economic assessments with regard to BVDV prevention and/or mitigation. Thus, the aim of this systematic review was to review financial and/or economic assessment studies of pre- Due to the high number of studies available, the search terms "control program/me", "diseases losses" and "production losses" were set in quotation marks to ensure that the search engine returned only items where these combinations of terms were adjacent to each other. a The term "Scandinavian strategy" refers to the assessment of the BVDV status of herds by monitoring BVDV herd health using serological diagnostic methods, on clearance of the virus from the herd (Lindberg and Alenius, 1999) and livestock movement controls.
vention and/or mitigation activities of BVDV at national, regional and farm level. Studies were analyzed with particular focus on the type of financially and/or economically-assessed prevention and/or mitigation activities and financial and economic variables such as the efficiency, costs or benefits of these prevention and/or mitigation activities, the applied financial and/or economic and statistical assessment methods, the payers of prevention and/or mitigation activities, the assessed production systems, and the countries for which such assessments are available.
Material and methods
In order to identify studies focusing on the economics of BVDV prevention and/or mitigation activities at national, regional or farm level, an extensive literature search with no restriction on the date of study publication was performed between December 2014 and January 2015 using the following scientific online databases: PubMed (from 1879 until present), ISI Web of Science (from 1900 until present) and Scopus (from 1960 until present) . The restricted number of search terms used for this systematic review was applied to all databases and are described in Table 1 . No restrictions were made with respect to article language. Depending on the original article language, multilingual authors (CF, MT, MD, SH), as well as professional translators such as from the Department of East Asian Studies, University of Vienna, assisted in the translation of a variety of articles.
In the systematic review presented here, the term "prevention and/or mitigation" referred to the following activities as described by Lindberg and Houe (2005) : "prevention (biosecurity) measures, vaccination, monitoring and/or surveillance, testing and/or virus elimination measures e.g. within the context of control and/or eradication programs, and the subsidization of these activities e.g. compensation payments to the farmer for the elimination of PI animals" at national, regional and farm level. Our systematic review comprises financial and/or economic assessments of BVDV prevention and/or mitigation activities. Financial assessments focused on private entities (farm or organization level) and investigated (Otte and Chilonda, 2000) , e.g. the changes of cash flows (inflow and/or outflow), repayments, income statements, balance sheet, financial returns to the private sector regarding the implementation of BVDV prevention and/or mitigation activities, whereas economic assessments determine e.g. whether investments in the prevention and/or mitigation activities are justified to a society (national level) as a whole (Otte and Chilonda, 2000) .
Different financial and economic assessment methods exist, which can inform decision makers about the efficiency, costs or benefits of prevention and/or mitigation activities. Methods to assess efficiency include e.g. cost-benefit analysis, costeffectiveness analysis, least-cost analysis (Hoinville et al., 2013) , cost-utility analysis, budget impact analysis (Simoens, 2009) , or partial-budget analysis. The latter assesses the costs and benefits associated with a specific business change e.g. on a farm due to different production practices (Dijkhuizen et al., 1997; Rushton et al., 1999) . The results of these methods can be expressed in different forms. For instance, the outcome of a cost-benefits analysis can be presented as net costs/benefits, net present value, benefit-cost ratio or in form of internal rate of return (Rushton et al., 1999; Cellini and Kee, 2010) . Overviews of the different applied financial and economic methods as a function of different assessments levels (farm, regional or national) have been published by Dijkhuizen et al. (1995) , Rushton et al. (1999) , and Otte and Chilonda (2000) . However, in our systematic review the term "financial and/or economic assessments" not only covers studies that calculated the efficiency of prevention and/or mitigation activities using general financial or economic methods, but also studies that assessed the costs or benefits (e.g. prevented losses) regarding economic impacts of prevention and/or mitigation activities by describing the monetary costs or benefits of eradication programs e.g. in Tabular overviews. Thus, the systematic review presented here provides as much detail as possible on the economics of BVDV prevention and/or mitigation.
In order to identify relevant studies for the purpose of this review a two-step process was applied. First, all articles identified via the search terms in the databases (primary articles) were reviewed in full by one reviewer (BP) and were reviewed again for validation by three independent reviewers (VR, JB, KL) with different educational backgrounds (economics, veterinary medicine and statistics). Two of these reviewers read all articles in full and one reviewer received notes from the first reviewer (BP). In a second step, the references lists of the relevant primary articles were screened by title and abstract according to the search terms defined in Table 1 (secondary articles) . Of these, studies that contained financial and/or economic assessments of the considered prevention and/or mitigation activities were also reviewed and validated in full. Any disagreements regarding the inclusion of studies were resolved by consensus through discussion between all reviewers.
Primary and secondary articles were excluded if they were not available in full or were published as a specific document type such as a book chapter (primary exclusion criteria). Additionally, studies were excluded which had no own inherent financial and/or economic assessments such as review studies or studies that did not provide monetary outcomes or studies not related to the topic, such as those that did not assess prevention and/or mitigation activities economically (e.g. studies which focused only on prevention and/or mitigation or production losses) or those which focused on BVDV in species other than cattle (secondary exclusion criteria). The number of identified articles (primary and secondary articles) and the exclusion process (primary and secondary exclusion criteria) are illustrated in Fig. 1 .
Each relevant article and conference proceeding was evaluated in terms of the financial and economic assessment criteria initially described by Evers et al. (2005) and modified for the purpose of this review. The evaluation scale is shown in Table 2 and ranged from completely fulfilled (class 1) to scarcely fulfilled (class 3) the criteria. Additionally, studies from all classes have been analyzed according to the criteria provided in Table 3 . To perform a descriptive statistical analysis, we grouped the analyzed criteria of the studies into different categories (Table 3) .
Results
Overall, 7% (n = 35) of the identified articles (N = 487) published financial and/or economic assessments (Fig. 1 ) of prevention and/or Class 1 was used as baseline. N.B "Conducting a sensitivity analysis" was only used as evaluation criteria in studies with a modeling approach.
mitigation activities with regard to BVDV and were considered relevant for this systematic review. The majority of the studies were published after 2000 (74%; n = 26), in particular in 2005 (13%; n = 5). Approximately, half of the studies (n = 18) were identified as modeling studies. According to the predefined criteria listed in Table 2 , 23% (n = 8) of these financial and/or economic assessments could be assigned to class 1, 34% (n = 12) to class 2 and 43% (n = 15) to class 3. The studies aimed mainly to assess prevention and/or mitigation activities in economic terms (n = 29) or to describe them (n = 6). Fig. 2 shows that the majority of financial and/or economic assessments are based primarily in the area of control and/or eradication programs (34%; n = 12), followed by individual culling, control and/or diagnostic testing strategies (17%; n = 6). The remaining studies cover more than one area, with most of the intersections being found between the areas of prevention (e.g. biosecurity) and vaccination strategies. Most frequently, financial and/or economic assessments related to BVDV prevention and/or mitigation activities were performed in Europe (77%; n = 27), dominated by the United Kingdom (Scotland), Norway, Germany, and Switzerland; non-European countries, such as the United States of America, New Zealand and Canada, made up 23% of the studies (n = 8). Fig. 2 shows that Norway carried out most economic assessments in the control and eradication area, whereas the United Kingdom, in contrast to the other countries, often assessed the costs and/or the benefits of vaccination strategies and the United States assessed mostly individual culling, control and diagnostic testing strategies at the farm level. Fig. 2 also reveals that only a small number of studies (n = 3) economically assessed surveillance and monitoring programs.
The 35 studies of prevention and/or mitigation activities included in this systematic review were classified according to the analyzed financial and/or economic variables and payers of prevention and/or mitigation activities ( Fig. 3a and b) , applied financial and/or economic and statistical methods ( Fig. 3c and d) , assessed production systems and the geographical level of the financial and/or economic assessments (see Table 3 ). Fig. 3a shows that the majority of the studies calculated the efficiency (relation between costs and benefits or comparison of various activities in terms of their costs) at farm level (n = 9) rather than at national (n = 7) or regional level (n = 1). The studies at farm level primarily assess the efficiency of prevention (e.g. biosecurity) measures (14%; n = 5) such as the profitability of closed farm systems or avoiding contact with PI animals through quarantine or reducing the replacement rate. Further studies (11%; n = 4) analyze the efficiency of testing or vaccination strategies. Examples of this include attempts to make herd-level control measures more economical by determining e.g. the optimal number of samples needed to detect PI animals. In general, one third of the studies focused on the prevented production losses due the implementation of prevention and/or mitigation activities at the farm level. The other studies at farm level analyzed the least cost options of different diagnostic testing schemes. Studies at national or regional level revealed a net benefit/cost (compared the costs of the program with the prevented production losses) of hypothetical or previously implemented control and/or eradication programs (17%; n = 8) after a specific period of time. In total, 84% of all studies at the national and regional level focused on the eradication, 11% on the control and 5% on the prevention (through biosecurity measures) of BVDV. Individual costs or benefits were mainly published in studies at all geographical levels and focused on the costs and benefits of national or regional control and/or eradication programs (n = 10), prevention (biosecurity) programs (n = 3) and, the costs or benefits of different testing strategies (n = 5).
In total, 65% (n = 23) of all analyzed studies mentioned the payers of the prevention and/or mitigation activities (Fig. 3b ), who were primarily located in the private sector. Germany provided the most information regarding subsidized financing of BVDV control and eradication programs through farmer organizations such as animal disease funds (Tierseuchenkasse). Fig. 3c shows that most studies at all geographical levels describe the costs and benefits (38%; n = 14) e.g. in a tabular listing, followed by studies that applied partial budget analysis (18%; n = 7), cost-benefit analysis (16%; n = 6) or other financial and/or economic methods such as production function, economic welfare methodology, The area "control" summarized assessments to reduce the disease prevalence. The area "eradication" summarized assessments to provide a continued absence of disease. The area "prevention" summarized assessments of biosecurity measures such as avoiding contact with PI animals, no further purchase, testing of cattle before movement etc. The area "monitoring" covered all assessments to monitor the disease without a pre-defined action plan (Hoinville et al., 2013) . The area "surveillance" covered all assessments to detect the presence or demonstrate the absence of the disease with a pre-defined action plan. The area of "vaccination" covered all assessments were vaccination strategies were mentioned. The area "individual culling/control/diagnostic testing" summarized assessments of single mitigation activities at farm level. The area "combination of these areas" covered more than one area, e.g. the use of vaccine to prevent BVDV infection covers both the "prevention" and "vaccination" areas. Geographical level National level Regional level Farm level A "regional level" covers one or more than one geographical units (e.g. regions, provinces or states) of a country, but did not cover the entire country (representative proportion of the entire country = "national level"). Financial assessments at herd level or per animal or per farm were assigned to the geographical category "farm level".
Financial/ Economic variables Efficiency Cost Benefit
Studies that determine the relationship (e.g. net present value or benefit-cost ratio) between monetary assessments of prevention and/or mitigation activities (Input) and avoided production losses (Output) were assigned to the category "efficiency". In this context, two categories can be distinguished: Optimization (maximization of the net benefit) and Acceptability (prevented production losses averted through mitigation activities should at least cover its costs). Studies that determine the minimum costs can be distinguished in least costs or cost-effectiveness (without quantification of the monetary benefit) with reference to ensuring the target of prevention and/or mitigation activities were included in the category "efficiency" (Hoinville et al., 2013) . The term "cost" covered fixed (costs vary in the long-term) and/or variable costs (costs vary in the short-term) and/or expenses and/or in-kind contribution/opportunity costs (vary in the long and/or short term) (Pinior et al., 2015a,b) . The term "benefit" included the economic value of international trade, the mitigation of production losses, testing strategies, losses saved, new revenue. Payers Private sector Public sector Payers in the "private sector" covers farmers, farmer organizations, and the farming industry in general. Payers in the "public sector" covers governments and political authorities in general.
Methodology Financial/Economic Statistical
The methodologies in the category "financial and/or economic" range from the descriptions of costs/benefits to general methods such as cost-benefit analysis, partial budget analysis. "Statistical" methodologies range from basic statistics such as calculation of confidence intervals, odds ratio (assigned to category N.S.) to stochastic (simulation) models. Production system Cattle Dairy Beef Dairy and Beef Calves and youngstock
The term "cattle" summarized all studies, for which more than one production system (ranged from dairy to calves and youngstock systems) could be determined.
a The assignment of a study to the categories is based on their study outcome.
return on investment calculation, linear programing or contingency claim analysis. Beside the usage of financial or economic methods, statistical methods were also applied. The most commonly applied statistical methods were stochastic (simulation) models. Sensitivity analysis and PERT distributions were mainly performed in connection with a stochastic model in order to evaluate the uncertain variables. Stochastic (simulation) models included the methodology of Markov Chain/state-transition models and/or Monte Carlo-methods, Reed-Frost (SIR) models and Bayesian approaches. With regard to the different production systems, we have identified that dairy production systems were approximately eight times more likely to be assessed economically with regard to BVD prevention and/or mitigation activities than calf and youngstock production systems. Beef production systems were primarily assessed by the United States and the United Kingdom. The results indicate that three times more countries take the dairy sector into account than beef production systems. Overall, 51% (n = 18) of the studies made direct reference to cattle in general. The analyses of the prevention and/or mitigation activities at the geographical level (studies from all classes 1-3) show that 34% (n = 12) of the assessments could be allocated to national level, 20% (n = 7) to regional level, and 46% (n = 16) to farm level. A tabular overview of these studies (studies assigned to classes 1-3) regarding the considered prevention and/or mitigation activities, applied assessment methods, and financial and/or economic outcomes of the studies can be found in Tables 4-6 .
Discussion
As far as the authors are aware, this is the first global systematic review to be carried out regarding the economics of BVDV prevention and/or mitigation activities. In contrast to other reviews with a similar focus ( The costs of the mitigation activities were calculated to be EUR3.4-4.4 million. The NPV was not calculated. The production losses amounted to EUR29.1-73-9 million.
N.S. = not specified; a presumed; N.B. Monetary values have been converted into euros (without adjusting for inflation). Prevention and/or mitigation activities in brackets were passively included in the calculation. Costs are expenses of prevention and/or mitigation activities, unless stated otherwise; Benefits are e.g. losses prevented, new revenue, economic value of testing; NPV = Net present value is defined as the sum of total discounted benefits minus the sum of total discounted costs; Net benefits/costs = Total costs are subtracted from the total benefits.
Table 5
Overview of assessed prevention and/or mitigation activities, applied methods and study outcomes at regional level. N.S. = not specified; a not presented in million EUR; N.B. Monetary values have been converted into euros (without adjusting for inflation). Prevention and/or mitigation activities in brackets were passively included in the calculation. Costs are expenses of prevention and/or mitigation activities, unless stated otherwise; Benefits are e.g. losses prevented, new revenue, economic value of testing; NPV = Net present value is defined as the sum of total discounted benefits minus the sum of total discounted costs; Net benefits/costs = Total costs are subtracted from the total benefits. Testing the risk groups of a farmer was in the most cases beneficial. The removal of PI cattle can also reduce the infection risk for other herds and thus it could be also beneficial to the total Danish cattle population.
N.S.=not specified; a not presented in million EUR; b presumed, c It was assumed that vaccination was only considered in BHV-1 introduction; N.B. Monetary values have been converted into euros (without adjusting for inflation). Prevention and/or mitigation activities in brackets were passively included in the calculation. Costs are expenses of prevention and/or mitigation activities, unless stated otherwise; Benefits are e.g. losses prevented, new revenue, economic value of testing; NPV = Net present value is defined as the sum of total discounted benefits minus the sum of total discounted costs; Net benefits/costs = Total costs are subtracted from the total benefits. 1 http://www.ers.usda.gov/topics/animal-products/cattle-beef/statistics-information.aspx (accessed 12 August 2016). 2 https://www.gov.uk/government/statistical-data-sets/structure-of-the-livestock-industry-in-england-at-december (accessed 02 August 2016). 3 https://webcache.googleusercontent.com/search?q=cache:IWLU5CR2wvcJ:https://www.gov.uk/government/uploads/system/uploads/attachment data/file/414334/structure-dec2014-uk-19mar15. pdf+&cd=1&hl=de&ct=clnk&gl=at&client=firefox-b (accessed 12 August 2016).
4 https://www.gov.uk/government/uploads/system/uploads/attachment data/file/69220/pb13572-cattlebook-2008-090804.pdf (accessed 12 August 2016). 5 https://webcache.googleusercontent.com/search?q=cache:IWLU5CR2wvcJ:https://www.gov.uk/government/uploads/system/uploads/attachment data/file/414334/structure-dec2014-uk-19mar15. pdf+&cd=1&hl=de&ct=clnk&gl=at&client=firefox-b (accessed 12 August 2016)'.
6 http://webcache.googleusercontent.com/search?q=cache:oWcegphO9voJ:www.lic.co.nz/user/file/DAIRY%2520STATISTICS%25202012-13-WEB.pdf+&cd=2&hl=de&ct=clnk&gl=at&client=firefox-b (accessed 12 August 2016). 7 The Netherland Guilder (NLG) no longer exists. However, the Dutch authorities have published an official exchange rate to euros: http://www.dnb.nl/en/payments/exchanging-guilders/rules-for-exchanging-guilder-notes/ (accessed 12 August 2016).
8 http://webcache.googleusercontent.com/search?q=cache:x055cHHl4hsJ:www.uni-mannheim.de/edz/pdf/statinf/04/KS-NN-04-008-EN-N-EN.pdf+&cd=1&hl=de&ct=clnk&gl=at&client=firefox-b (accessed 12 August 2016).
Fig. 2.
Connection between the financial and/or economic assessments of each country (gray blocks around the circumference refer to the country abbreviation) and the corresponding areas in which the financial and/or economic assessment was conducted: Control and eradication program (red), surveillance (yellow), prevention (biosecurity) (green), vaccination (blue) and individual culling, control and diagnostic testing strategies (orange) are shown. The different colored lines in the circle represent the different studies assigned to specific countries. One color is associated with each individual study. Each study of a particular country is labeled with an abbreviation consisting of the first two letters of the main author of the study and the associated year of the publication (the corresponding full name of the author and the study name can be found in Table 4 -6). The thickness of the line represents the different assignments of the studies to the three different classes (see Table 2 ). Studies in class 1 are represented with the thickest line. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) et al., 2005) , our study incorporates a worldwide systematic search approach ( Fig. 1 ) over an extended period . To assess studies specifically emphasizing the financially and/or economic assessment of BVDV prevention and/or mitigation activities, we reviewed 487 articles in full regarding the type of financial and/or economically assessed BVDV prevention and/or mitigation activities, provided economic variables, such as the efficiency, costs or benefits of these prevention and/or mitigation activities, the applied economic and statistical assessment methods, the payers of prevention and/or mitigation activities, the assessed production systems and the countries for which such assessments are available. In all, 35 articles were considered for this systematic review.
The studies showed great variability regarding i) study design, such as modeling assumptions, herd size, included economic parameters, epidemiological initial situation (e.g. if BVDV is introduced to a naïve herd or if herds are BVDV endemic), ii) timescale of the financial and/or economic assessment, which ranged from a few months to 20 years (results not shown here), iii) type of assessed prevention and/or mitigation activities, which ranged from biosecurity measures at the farm level to national control and/or eradication programs, or iv) economic calculations, which ranged from net benefits to single costs of prevention and/or mitigation activities. Additionally, we found a great heterogeneity in the financial methods applied at farm level (Fig. 3c) . The economic methods applied at the national level were mostly cost-benefit Fig. 2a, 2c and 2d contain duplicates. One study comprises both the costs and benefits. Two studies include more than one financial and/or economic methods such as partial budget analysis and cost-benefit analysis; Production function and linear programing. Fig. 2d covers a study, which applied a simulation model with a regression analysis. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
analyses and economic descriptions of the costs/benefits of BVDV control and/or eradication program. However, one limitation of this method is that the cost-benefit ratio does not provide useful information about the use of potentially superior alternative mitigation activities. Thus it cannot be applied as a criterion for optimal resource allocation, which is a necessary consideration as public resources become more limited . In order to inform decision-makers about efficient resource allocation of mitigation activities more ex-ante assessments (prospective) at national/regional level are necessary . Approximately 56% of the economic assessments of BVDV mitigation activities at national and regional level in this systematic review were ex-post-assessments (retrospective). Our systematic review revealed that none of the analyzed studies incorporated all of the following items which should, in the authors' opinion, be taken into account when conducting an economic efficiency analysis (Rushton et al., 1999) : price elasticities, societal welfare effects, technical efficiency , discount rate, the costs and benefits of national BVDV programs and alternative strategies. Further identified issues at all geographical levels were the reporting of currencies, time frame and cattle population size over time. All these issues made a comparison between the studies difficult. These issues have also been reported in other systematic reviews of animal health economics such as those reporting on control and eradication programs of bovine tuberculosis (Caminiti et al., 2016) . In some studies, we also noted an inconsistent mixture of the economic terminology, in that studies used cost-benefits analysis and cost-effectiveness evaluation as synonyms while it was clear that differences existed between them (see Table 2 ). Since these were heterogeneous studies, an in-depth comparison and statistical analysis are difficult to carry out. All these factors restricted our analysis to a descriptive summary of the results obtained. Consequently, no recommendations can be made with respect to the economically optimal prevention and/or mitigation strategy, as this clearly depends on the study design, herd (Houe, 2003; Moennig et al., 2005) and country-specific conditions.
Our systematic review identified only four countries (Norway (Valle et al., 2000 (Valle et al., , 2005 , Ireland (Stott et al., 2012) , France (Dufour et al., 1999) , and Switzerland ) that demonstrated that the implementation and inherent costs of mitigation activities at the national level are justified economically after a specific time period. Additionally, some studies (Bitsch and Rønsholt, 1995; Houe, 1999 Houe, , 2003 concluded that eradication in Denmark would be also efficient if the direct (Houe et al., 1993) and indirect costs, calculated in different studies, would be compared. Only one study from the United Kingdom showed that control measures at the national level would not be economically justified (Bennett and Done, 1986) . No comparison of the costs and benefits of control and/or eradication programs at the regional level were found. It is perhaps surprising that no more studies concerning efficiency at the national or regional levels are available, in particular for countries that conducted mitigation activities as part of compulsory or voluntary regulations, 1 such as Austria, Belgium, Germany, Sweden, Finland or regions in Canada, Italy, the Netherlands, the United States, and Spain. Howe et al. (2012) emphasized the need for a closer integration of economic frameworks in the planning of animal disease mitigation activities. Reasons for the lack of assessments of the efficiency of mitigation activities could be the difficulty in accessing or identifying economic data on a large-scale and/or voluntary control and eradication activities, such as in the Netherlands and United States, where a lack of national coordination exists. A further reason could be that animal health economics is a relatively young discipline (Houe, 2003) and these methods have the potential to be improved . In contrast to studies focusing on other animal diseases (Pinior et al., 2015a) , we did not find financial and/or economic assessments of prevention and/or mitigation activities with regard to BVDV, which revealed heterogeneous temporal and spatial distributions of the costs and/or benefits between different regions of a country.
However, the economic optimum depends on the monetary benefits of avoided production losses, monetary expenditure of mitigation activities and technical efficiency. Therefore, optimal economic efficiency (maximum net benefit) of mitigation activities is defined when the marginal benefits (prevented production losses) cover at least the marginal mitigation costs . The marginal benefits are often measured as the avoided direct losses averted through prevention and/or mitigation activities and are challenging to quantify. Difficulties in calculating production losses may reflect variations in the severity of the outbreak itself, which depends, for example on herd immunity, the time and duration of infection, virulence of the infecting virus strain (BVDV genotypes 1 or 2) and methodological differences, such as selection of herds on the basis of clinical and non-clinical outbreaks (Carman et al., 1998; Houe, 1999; Fourichon et al., 2005; Barrett et al., 2011) . Perhaps this is the reason why one third of the studies (n = 12) provided only the costs or benefits of prevention and/or mitigation activities at national and regional level instead of analyzing financial and/or economic efficiency. In this context, we have identified that the majority of studies neglected the virulence of the virus strain in order to estimate the production losses (results not shown here), which influenced the efficiency conclusions of prevention and/or mitigation activities. Another explanation for the lack of efficiency calculations could be that not all countries have prevention and/or mitigation activities in place, or that if countryspecific financial and/or economic assessments are available, they are not in the public domain or studies have not been identified by the selected databases, restricted search terms, time frame or because of predefined exclusion criteria. Barrett et al. (2011) and Hessman et al. (2009) pointed out that economic data regarding BVDV in beef herds are more limited than in dairy herds. Our analyses can confirm this claim and indicate that the countries and studies included here take the dairy production system three times more often into account than beef production systems. Dairy production systems were approximately eight times more frequently assessed than calf and youngstock production systems. We identified a number of studies that used data from dairy production systems to estimate production losses in the beef sector. However, applying data in this way should be treated with caution, as the infection status of beef herds is generally lower than that of dairy herds (Bitsch and Rønsholt, 1995) . Most beef herds have a limited breeding season and thus a shorter risk period for PI animal development (Smith et al., 2014) . With regard to the epidemiology of BVD, other differences exist between dairy and beef herds and details of these have been published by Gunn et al. (2004) . The differing infection statuses between dairy and beef cattle can result in the finding that the negative effects of BVDV are more easily measurable in dairy (e.g. reduced milk production) than in beef production systems; and perhaps this is why more data are available. A further explanation for the different number of assessed production systems could be that it is difficult to motivate beef cattle owners, for economic reasons, to implement prevention and/or mitigation activities because individual blood samples taken from beef herds are less cost-efficient than bulkmilk testing in the dairy sector Lindberg, 1998, 2005) . Previous studies have pointed out that BVDV is largely perceived as an individual farmer problem (Heffernan et al., 2016) instead of a public issue. Perhaps this is the reason why farmers or farmer organizations were identified as the main payer of BVDV prevention and/or mitigation activities in this systematic review. A study by Weldegebriel et al. (2009) demonstrated that the cost of eradication activities should be shared between taxpayers and farmers of infected cattle rather than being borne completely by livestock owners due to subsequent benefits to the consumer. Alternatively, government decisions on intervention and financial support may be influenced by the perceived time frame and ease with which animal diseases can be managed (Carslake et al., 2011) , whereby BVDV is an animal disease that is difficult to control. It has been shown that farmer motivation to participate in BVDV programs is influenced by financial incentives (Brützke et al., 2011; Heffernan et al., 2016) and thus cost-sharing between the private and public sector appears to be an optimum solution with regard to control or eradication of BVDV.
A major subject in the veterinary field is trade in livestock and livestock products, not only because it represents an important economic sector, but also because it is one of the major routes for the spread of animal diseases (Fritzemeier et al., 2000; Pinior et al., 2012a Pinior et al., ,b, 2015c Lebl et al., 2016 ). We did not find studies that assessed the costs of international trade restrictions as a (hypothetical) prevention or mitigation measure. However, considering the possible spread of BVD between contiguous herds (Graham et al., 2016) , it appears to be more effective to implement prevention and/or mitigation activities at regional or national level rather than at individual farms (Houe, 2003) .
Although, the financial and/or economic assessment of prevention and/or mitigation activities is considered vital by public health authorities to demonstrate that prevention and/or mitigation activities were economically efficient, most veterinary studies neglect this type of analysis (Drewe et al., 2012) . Our systematic review has shown that this is particularly true with respect to BVDV mitigation at national or regional level. More studies are necessary in order to demonstrate the long-term economic efficiency of BVDV mitigation programs. An economic efficiency analysis could motivate and assist the private and/or public sectors in the decision making process, when deciding whether to introduce prevention and/or mitigation activities on a large-scale or determine the most efficient and effective prevention and/or mitigation strategies.
Conclusion
Our analyses highlight a distinct lack of accurate economic studies regarding the efficiency of BVDV prevention and/or mitigation activities, in particular at national and regional levels, and with respect to the individual production systems. Additionally, issues were found in the methodology of some studies at all geographical levels, such as neglecting price changes, discount rate or differences in cattle population size over time. Statistical analyses of the reviewed studies could not be carried out due to the great variability in study designs and outcomes. Consequently, no recommendations on economic prevention and/or mitigation strategies can be made because this clearly depends on study, herd and country-specific conditions. We can confirm the need for more well-designed studies (e.g. strict implementation of economic efficiency analyses) in animal health economics in order to support the private and public sector in the decision-making process on prevention and/or mitigation activities and to demonstrate the long-term economic efficiency of these activities. To fulfill this obligation, however, researchers must gain access to reliable information on costs and benefits of prevention and/or mitigation activities, which currently represent a limiting factor in the field of animal health economics.
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